IMMUNOTHERAPY WITH BINDING AGENTS
The present invention provides agents, such as soluble receptors, antibodies, and small molecules that modulate the immune response. In some embodiments, the agents activate or increase the immune response to cancer and/or a tumor. In some embodiments, the agents inhibit or suppress the immune respo...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English French German |
Published |
02.11.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention provides agents, such as soluble receptors, antibodies, and small molecules that modulate the immune response. In some embodiments, the agents activate or increase the immune response to cancer and/or a tumor. In some embodiments, the agents inhibit or suppress the immune response to cancer and/or a tumor. The invention also provides compositions, such as pharmaceutical compositions, comprising the agents. The invention further provides methods of administering the agents so a subject in need thereof. In some embodiments, the invention provides methods of using the agents for cancer immunotherapy. In some embodiments, the invention provides methods of using the agents for treatment of autoimmune diseases. |
---|---|
Bibliography: | Application Number: EP20140874789 |